Assignee
SORRISO PHARMACEUTICALS INC
US·10 granted patents·4 pending applications·17 citations·filing 2019–2025
Top patents by PatentIndex Score
14 records- 0193US11623952B2IL-23 and TNF-alpha binding bi-specific heavy chain polypeptidesSORRISO PHARMACEUTICALS INC·Filed 2022·Granted Apr 11, 2023·4 cites·15 claims
- 0292US12234279B2Peptide construct having a protease-cleavable linkerSORRISO PHARMACEUTICALS INC·Filed 2021·Granted Feb 25, 2025·2 cites·16 claims
- 0392US11667719B2VHH immunoglobulin chain variable domain that binds to IL-7R and methods of use thereof for treating autoimmune and/or inflammatory diseasesSORRISO PHARMACEUTICALS INC·Filed 2022·Granted Jun 6, 2023·5 cites·16 claims
- 0490US12173054B2PolypeptidesSORRISO PHARMACEUTICALS INC·Filed 2020·Granted Dec 24, 2024·2 cites·16 claims
- 0588US12247079B2Polynucleotides encoding, and method of making, a polypeptide comprising a VHH which binds interleukin-receptor (IL-7R)SORRISO PHARMACEUTICALS INC·Filed 2020·Granted Mar 11, 2025·2 cites·15 claims
- 0682US11684677B2CompositionsSORRISO PHARMACEUTICALS INC·Filed 2019·Granted Jun 27, 2023·2 cites·14 claims
- 0776US12098197B2Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseasesSORRISO PHARMACEUTICALS INC·Filed 2022·Granted Sep 24, 2024·0 cites·11 claims
- 0875US2023287098A1PolypeptidesSORRISO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0970US2024277864A1CompositionsSORRISO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1067US11401327B2Polypeptides which bind to interleukin-6 receptor (IL-6R)SORRISO PHARMACEUTICALS INC·Filed 2020·Granted Aug 2, 2022·0 cites·8 claims
- 1167US2025388655A1Peptide construct having a protease-cleavable linkerSORRISO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1264US2025277043A1Polynucleotides encoding, and method of making, a polypeptide comprising a vhh which binds interleukin- receptor (il-7r)SORRISO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1361US12559552B2IL-23 and TNF-alpha binding bi-specific heavy chain polypeptidesSORRISO PHARMACEUTICALS INC·Filed 2020·Granted Feb 24, 2026·0 cites·19 claims
- 1450US12570736B2CompositionsSORRISO PHARMACEUTICALS INC·Filed 2020·Granted Mar 10, 2026·0 cites·22 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →